Trials / Completed
CompletedNCT01782924
A Phase 3 Clinical Study of KHK4827
An Extension Study in Subjects With Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 145 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate safety and efficacy of long-term exposure of KHK4827 in subjects with moderate to severe plaque psoriasis who have completed the preceding Study 4827-002.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KHK4827 |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2013-02-04
- Last updated
- 2015-02-16
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01782924. Inclusion in this directory is not an endorsement.